Benutzer: Gast  Login
Titel:

Enzalutamide after docetaxel and abiraterone therapy in metastatic castration-resistant prostate cancer.

Dokumenttyp:
Journal Article
Autor(en):
Schmid, Sebastian Christoph; Geith, Alexander; Böker, Alena; Tauber, Robert; Seitz, Anna Katharina; Kuczyk, Markus; von Klot, Christoph; Gschwend, Jürgen Erich; Merseburger, Axel Stuart; Retz, Margitta
Abstract:
Enzalutamide is a novel antiandrogen which is approved for the treatment of metastatic, castration-resistant prostate cancer (mCRPC) after taxane-based chemotherapy. The efficacy of enzalutamide after the sequence docetaxel and abiraterone is not proven.Thirty-five mCRPC patients in the German compassionate use program, who received enzalutamide after progression with taxane-based chemotherapy and abiraterone were prospectively evaluated. The endpoints of the study were overall survival, radiolo...     »
Zeitschriftentitel:
Adv Ther
Jahr:
2014
Band / Volume:
31
Heft / Issue:
2
Seitenangaben Beitrag:
234-41
Sprache:
eng
Volltext / DOI:
doi:10.1007/s12325-014-0092-1
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/24442834
Print-ISSN:
0741-238X
TUM Einrichtung:
Urologische Klinik und Poliklinik
 BibTeX